This variant could contribute to a protective role against the haploinsufficient forms of autoimmune lymphoproliferative syndrome (ALPS, OMIM 601859) [93–98] by increasing the expression of FAS in heterozygous loss-of-function variant carriers. This evidence concerns the gene FAS and autoimmune lymphoproliferative syndrome.